<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03364387</url>
  </required_header>
  <id_info>
    <org_study_id>MINOCA-TR</org_study_id>
    <nct_id>NCT03364387</nct_id>
  </id_info>
  <brief_title>Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population</brief_title>
  <acronym>MINOCA-TR</acronym>
  <official_title>The Clinical Profile, Management and Long-Term Outcomes of Patients With Acute Coronary Syndrome and Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiovascular Academy Society, Turkey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiovascular Academy Society, Turkey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to analyze the Demographics, Clinical Profiles, Management,&#xD;
      in-Hospital and Long-Term Outcomes of Patients with Acute Coronary Syndrome Syndrome And&#xD;
      Myocardial Infarction with Non-obstructive Coronary Artery Disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute coronary syndrome is leading causes of death worldwide. Although, &gt;90% of these&#xD;
      patients had of culprit coronary lesion, a significant proportion of them had no any&#xD;
      angiographic evidence of obstructive coronary arteries. Exact mechanism of the myocardial&#xD;
      infarction remains unclear of these patients. However, MI registries have reported that the&#xD;
      5% to %10 of MI patients have no evidence of obstructive coronary artery disease.&#xD;
&#xD;
      There is lack of any data regarding prevalence, demographics, patients' profile, management,&#xD;
      and outcome of this clinical entity in Turkish population. This registry aims to obtain these&#xD;
      data in Myocardial Infarction with Non-obstructive Coronary Artery Disease patients in&#xD;
      Turkish population.&#xD;
&#xD;
      Although there are huge data in this issue from different country and geographic areas, to&#xD;
      date no any national data about prevalence, demographics, management and in-hospital outcomes&#xD;
      of AF patients who admitting with cute coronary syndrome. With this rationale the registry&#xD;
      also aims to obtain demographics, clinical profile, management, and in-hospital outcome of AF&#xD;
      in Turkish Acute coronary syndrome population.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 5, 2018</start_date>
  <completion_date type="Actual">June 15, 2018</completion_date>
  <primary_completion_date type="Actual">May 15, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composites of Myocardial Infarction, Hospitalization, Revascularization, Death</measure>
    <time_frame>12 months</time_frame>
    <description>Re-infarction, Any cause or Cardiovascular Hospitalization or Death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Atrial Fibrillation</measure>
    <time_frame>12 months</time_frame>
    <description>Any type of atrial fibrillation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure</measure>
    <time_frame>12 months</time_frame>
    <description>Acute decompensated heart failure with or without cardiogenic shock</description>
  </secondary_outcome>
  <enrollment type="Actual">16026</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Atrial Fibrillation</condition>
  <condition>Diabetes Mellitus</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Fasting venous blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will consisted patients with acute coronary syndrome undergoing invasive&#xD;
        diagnostic coronary angiography.&#xD;
&#xD;
        Patients will eligible to take part in the study if they will fulfilled the criteria for&#xD;
        acute myocardial infarction.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients older than 18 years&#xD;
&#xD;
          2. Evidence of an MI as defined any one of the following criteria:&#xD;
&#xD;
             Detection of a rise and/or fall of cardiac biomarker values [preferably cardiac&#xD;
             troponin (cTn)] with at least one value above the 99th percentile upper reference&#xD;
             limit (URL) and with at least one of the following:&#xD;
&#xD;
             i. Symptoms of ischaemia. ii. New or presumed new signiﬁcant ST-segment-T wave (ST-T)&#xD;
             changes or new left bundle branch block (LBBB).&#xD;
&#xD;
             iii. Development of pathological Q waves in the ECG. iv. Imaging evidence of new loss&#xD;
             of viable myocardium or new regional wall motion abnormality.&#xD;
&#xD;
             v. Identiﬁcation of an intracoronary thrombus by angiography.&#xD;
&#xD;
          3. Invasive diagnostic coronary angiography (IDCA) findings to allow determination of the&#xD;
             presence /absence of obstructive coronary artery disease&#xD;
&#xD;
          4. Signed informed consent form to trial participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability/Refused to provide informed consent&#xD;
&#xD;
          2. Age below 18 years&#xD;
&#xD;
          3. Patients with unstable angina pectoris (ACS without increase and/or decrease of a&#xD;
             cardiac biomarker, preferably high-sensitivity cardiac troponin, with at least one&#xD;
             value above the 99th percentile of the upper reference limit)&#xD;
&#xD;
          4. Patients refused invasive diagnostic coronary angiography&#xD;
&#xD;
          5. Myocardial infarction associated with revascularization procedures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Emin Alioğlu</name>
      <address>
        <city>Izmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>November 30, 2017</study_first_submitted>
  <study_first_submitted_qc>December 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2017</study_first_posted>
  <last_update_submitted>July 23, 2018</last_update_submitted>
  <last_update_submitted_qc>July 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>MINOCA</keyword>
  <keyword>Myocardial Infarction</keyword>
  <keyword>Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

